Old Web
English
Sign In
Acemap
>
authorDetail
>
Tanya S. Rosenberg
Tanya S. Rosenberg
AbbVie
Venetoclax
Oncology
in patient
Internal medicine
Medicine
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Neutropenia analysis of venetoclax monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia: Pooled data from VENICE-I and -II Phase IIIb trials.
2020
Journal of Clinical Oncology
Mary Ann Anderson
Matthew S. Davids
Arnon P. Kater
Tara Cochrane
Fatih Demirkan
Yair Herishanu
Brian Leber
E. A. Nikitin
Abdullah Masud
Tanya S. Rosenberg
Simon Sharmokh
Stan Fort
Francesco Forconi
Show All
Source
Cite
Save
Citations (0)
CLL-088: Neutropenia Analysis of Venetoclax Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Pooled Data from VENICE-I and -II Phase 3b Trials
2020
Clinical Lymphoma, Myeloma & Leukemia
Mary Ann Anderson
Matthew S. Davids
Arnon P. Kater
Tara Cochrane
Fatih Demirkan
Yair Herishanu
Brian Leber
Eugene Nikitin
Abdullah A. Masud
Tanya S. Rosenberg
Simon Sharmokh
Stan Fort
Francesco Forconi
Show All
Source
Cite
Save
Citations (0)
Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings
2020
Blood
John F. Seymour
John G. Gribben
Matthew S. Davids
Anthony R. Mato
Jeff P. Sharman
Aimee Cyr
Cynthia Bartkus
German Pena
Michelle Boyer
Simon Sharmokh
Tanya S. Rosenberg
William G. Wierda
Show All
Source
Cite
Save
Citations (0)
1